I am a partner and managing director with the medtech M&A practice at RM Global Partners LLC, a leading boutique investment bank. Our website www.rmglobal.com provides a good overview of our team and activities. I also do strategic advisory work for life science clients with a particular focus and expertise in the medical device and diagnostic space with over 25 years of experience.

Capture Vascular has designed and FDA cleared, a novel proprietary proximal protection and thrombectomy technology that addresses the unmet need for improved and more effective clot removal in multiple vascular locations.

Serving as active Board Member and strategic consultant to early stage start-up company which has identified a novel biomaterial that coats the aortic aneurysmal wall and inhibits growth. Proof of concept already obtained through multiple animal and human tissue studies. Currently partnering with CEO to identify Series B funding to complete First-In-Man Study and demonstrate clinical effectiveness.

Retained after acquisition of Invatec to lead US commercial business and integration of organization into Medtronic. Served as member of global management board.• Expanded distribution channel 300% while integrating all support functions into MDT within 90 days with zero disruption to customer base• Increased sales over 40% in first year despite many distractions with integration.• Led acquisition and integration team in key strategic purchase to broaden product portfolio. • Achieved 100% staff retention during transition period.

As member of global management team, led US Operations for the fastest growing medical device companies in the world. Established a direct commercial presence in the US over 40 employees within three months. • Hired and built an organization with all key functions necessary to run a stand alone company except R&D and manufacturing. • Established two strategic alliances to enhance product portfolio and expand US presence.• Gained FDA clearance and approval on multiple products including PTA catheters, stents and embolic protection devices. • Played key role in the sale of Invatec to Medtronic in April 2010, less than 2 years after establishing US business.

Reported to Board of Directors with full P&L responsiblity for a start-up entering commercial phase in one of the largest untapped medical markets. • Raised $16M in venture capital in two rounds of financing during tenure as CEO.• Immediately established US.headquarters, hired team of 24 people ,and transferred from Australia all commercial and distribution functions. • Within 12 months company had penetrated over 140 accounts and was close to breakeven, generating $7M in annual revenue with minimal reimbursement.• Successfully lobbied for over $1M in US government grants for ongoing research.• Quickly established strong working relationships with medical societies and key opinion leaders (KOLs) within ENT (otolaryngologists) and neuro-otologists.

Reported to a Group President with autonomous, full P&L responsibility of this five-product category, $500M+ global business. On an annual basis, managed over $75M in R&D, $140M in sales & marketing, over $40M in medical, clinical and regulatory affairs, and over $100M in manufacturing costs. • Oversaw a management board of 13 people with a direct staff of four and a total complement of over 700 team members with manufacturing and R&D facilities in Mexico, The Netherlands, California, Florida, and New Jersey. • Developed and launched a series of innovative initiatives designed to dramatically improve research and development capability while significantly reducing the cost of manufacturing and enhancing quality of all manufactured goods. • Interfaced with a wide variety of internal and external personnel in cross-functional matrix environment, including over 150 physician leaders, regulators, vendors, and competitors as well as a vast general management peer group within the Johnson and Johnson family.

Reported to the Division President with direct responsibility for over 200 employees and over $280M in US sales as well as matrix responsibility for an additional $146M in international sales. • Promoted into position initially as Vice President of US sales. After 13 months, given full sales and marketing responsibilities for the organization with a mandate to aggressively grow sales both domestically and internationally. • Built, developed, and managed a cohesive new market development and professional education team which supported an annual growth rate of over 25% for five consecutive years. • Led company that had previously been third in the market to become worldwide market leader for peripheral vascular products. Worked directly with international affiliates and Managing Directors to develop the endovascular markets outside of the United States with annual growth rates over 40%. • Drove global product management team to provide strategic input that led to multiple product successes. • Oversaw development of a robust pipeline with 80% of sales contributed by products less than three years old.

Managed a $75M region, supervising five divisional sales managers and 45 sales representatives. Increased regional sales by over 30%.

Managed nine sales representatives and $10M in sales. Delivered over 35% growth and won Divisional Manager of the Year in 1998.

Supervised staff of 14 and managed a training budget of $3M. Successfully cross-trained three sales organizations and over 200 individuals upon acquisition of Cordis by Johnson and Johnson in 1996.

Managed development sales training programs for a sales force of over 700. Supported new training programs for over 125 representatives over a two year period. Designed and implemented cross training programs. Certified trainer in Negotiation Skills, Strategic Account Management and Face to Face Selling.

As senior sales rep, generated in excess of $600,000 in growth over a two year period, representing a 67% increase. Recognized in top 5% of sales force and as a member of the President's Club in 1990, 1991. One of only two sales people out of over 800 to win President's Club three consecutive years.

Grew territory over $300,000 and over 65% within 18 months. #1 performer in region out of 65 sales reps and ranked in the top 5% in the US. President's Club winner in 1989.